Year archive

Clover Biopharmaceuticals, Ltd. — 2024 filings

All 34 regulatory filings released by Clover Biopharmaceuticals, Ltd. (2197) in 2024, sourced directly from the official regulator.

34 Filings

2024 Period

2024 filings (34)

Filing	Released	Lang
Monthly Return of Equity Issuer on Movements in Securities for the Month ended November 30, 2024 Regulatory Filings	2024-12-05	English
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the Month ended September 30, 2024 Regulatory Filings	2024-11-06	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended October 31, 2024 Regulatory Filings	2024-11-06	English
VOLUNTARY ANNOUNCEMENT CLOVER ANNOUNCES POSITIVE CLINICAL DATA FOR RSV VACCINE CANDIDATE SCB-1019 COMPARED HEAD-TO-HEAD VERSUS GSK'S AREXVY Capital/Financing Update	2024-10-28	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended September 30, 2024 Regulatory Filings	2024-10-07	English
2024 Interim Report Interim / Quarterly Report	2024-09-19	English
Letter to Registered Shareholders - New Arrangement of Electronic Dissemination of Corporate Communications and Reply Form Regulatory Filings	2024-09-19	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2024 Regulatory Filings	2024-09-03	English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2024 Interim / Quarterly Report	2024-08-28	English
DATE OF BOARD MEETING Regulatory Filings	2024-08-15	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended July 31, 2024 Regulatory Filings	2024-08-05	English
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the Month ended June 30, 2024 Regulatory Filings	2024-07-17	English
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the Month ended April 30, 2024 Regulatory Filings	2024-07-17	English
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the Month ended May 31, 2024 Regulatory Filings	2024-07-17	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended June 30, 2024 Regulatory Filings	2024-07-03	English
FIFTH AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION Governance Information	2024-06-20	English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 20, 2024 Declaration of Voting Results & Voting Rights Announcements	2024-06-20	English
VOLUNTARY ANNOUNCEMENT CLOVER ANNOUNCES POSITIVE PRELIMINARY PHASE I RESULTS FOR BIVALENT RSV VACCINE CANDIDATE SCB-1019 IN OLDER ADULT AND ELDERLY COHORT Capital/Financing Update	2024-06-18	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended May 31, 2024 Regulatory Filings	2024-06-04	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended April 30, 2024 Share Issue/Capital Change	2024-05-06	English
Form of Proxy for Use at Annual General Meeting Proxy Solicitation & Information Statement	2024-04-25	English
(1). Proposed Grant of General Mandates to Repurchase Shares and to Issue New Shares; (2). Proposed Re-Election of the Retiring Directors; (3). Proposed Re-Appointment of Auditor; (4 AGM Information	2024-04-25	English
Notice of Annual General Meeting AGM Information	2024-04-25	English
2023 Annual Report Annual Report	2024-04-25	English
VOLUNTARY ANNOUNCEMENT CLOVER ANNOUNCES POSITIVE PRELIMINARY PHASE I RESULTS FOR BIVALENT RSV VACCINE CANDIDATE SCB-1019 IN INITIAL YOUNG ADULT COHORT Capital/Financing Update	2024-04-08	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended March 31, 2024 Share Issue/Capital Change	2024-04-03	English
GRANT OF OPTIONS PURSUANT TO THE POST-IPO SHARE OPTION PLAN AND GRANT OF RSUS PURSUANT TO THE RSU SCHEME Capital/Financing Update	2024-04-02	English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023 AND PROPOSED AMENDMENTS TO THE MEMORANDUM AND ARTICLES OF ASSOCIATION Annual Report	2024-03-26	English
DATE OF BOARD MEETING Regulatory Filings	2024-03-14	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended February 29, 2024 Regulatory Filings	2024-03-04	English
Letter to Non-Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications and Reply Form Regulatory Filings	2024-02-22	English
Letter to Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications and Reply Form Regulatory Filings	2024-02-22	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended January 31, 2024 Share Issue/Capital Change	2024-02-02	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended December 31, 2023 Share Issue/Capital Change	2024-01-03	English